| 30 |
2017 |
Thrombosis Research |
Whole blood coagulation assays ROTEM and T-TAS to monitor dabigatran t…
|
Taune V
|
| 26 |
2016 |
Journal of Clinical Medicine Research |
Evaluation of the antithrombotic effects of Rivaroxaban and Apixaban u…
|
Sugihara H
|
| 24 |
2016 |
Thrombosis and Haemostasis |
Monitoring of coagulation factor therapy in patients with von Willebra…
|
Ågren A
|
| 25 |
2016 |
Thrombosis Research |
Plasminogen activator inhibitor type 1 in platelets induces thrombogen…
|
Hosokawa K
|
| 23 |
2016 |
Heart Vessels |
Evaluation of the antithrombotic abilities of non-vitamin K antagonist…
|
Idemoto Y
|
| 22 |
2016 |
Journal of Thrombosis and Haemostasis |
Measurement of residual platelet thrombogenicity under arterial shear …
|
Yamazaki M
|
| 17 |
2015 |
Journal of Thrombosis and Haemostasis |
Assessment of platelet-derived thrombogenicity with the total thrombus…
|
Arima Y
|
| 15 |
2015 |
Int J Cardiol |
A novel quantitative assessment of whole blood thrombogenicity in pati…
|
Sueta D
|
| 12 |
2013 |
PLOS ONE |
Comparative evaluation of direct thrombin and factor Xa inhibitors wit…
|
Hosokawa K
|
| 11 |
2013 |
Journal of Cardiothoracic and Vascular Anesthesia |
Influences of Hemodilution and anticoagulation on antiplatelet P2Y12 t…
|
Ogawa S
|
| 10 |
2013 |
Thrombosis Research |
Antithrombotic effects of PAR1 and PAR4 antagonists evaluated under fl…
|
Hosokawa K
|
| 9 |
2013 |
British journal of Anaesthesia |
Haemodilution-induced changes in coagulation and effects of haemostati…
|
Ogawa S
|
| 6 |
2012 |
Thrombosis and Haemostasis |
Analysing responses to aspirin and clopidogrel by measuring platelet t…
|
Hosokawa K
|
| 3 |
2011 |
Microvascular Research |
A microchip flow-chamber system for quantitative assessment of the pla…
|
Hosokawa K
|
| 2 |
2011 |
Thrombosis and Haemostasis |
A comparative study of prothrombin complex concentrates and fresh-froz…
|
Ogawa S
|
| １ |
2011 |
Journal of Thrombosis and Haemostasis |
A novel automated microchip flow-chamber system to quantitatively eval…
|
Hosokawa K
|
